0007
Apeloa Pharmaceutical Co., Ltd. (000739)
Market Closed
4 Jul, 06:57
XSHE XSHE Primary ¥
14. 44
+0.05
+0.35%
¥
16.28B Market Cap
- P/E Ratio
1.27% Div Yield
10,725,930 Volume
- Eps
¥ 14.39
Previous Close Day Range
14.35 14.51
Year Range
12.7 18.96
Want to track 000739 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
000739 closed Friday higher at ¥14.44, an increase of 0.35% from Thursday's close, completing a monthly increase of 2.92% or ¥0.41. Over the past 12 months, 000739 stock lost -10.37%.
000739 is not paying dividends to its shareholders.
The last earnings report, released on Apr 09, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports.
Apeloa Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 30, 2014.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
000739 Chart
Loading, please wait...
Apeloa Pharmaceutical Co., Ltd. Dividends
| 0007 000739 1 month ago | Other | ¥0.36 Per Share |
| 0007 000739 23 May 2024 | Other | ¥0.32 Per Share |
| 0007 000739 22 May 2023 | Other | ¥0.3 Per Share |
| 0007 000739 18 Apr 2022 | Other | ¥0.28 Per Share |
| 0007 000739 29 Apr 2021 | Other | ¥0.24 Per Share |
Apeloa Pharmaceutical Co., Ltd. Earnings
| 9 Apr 2025 Date | | - Cons. EPS | - EPS |
| 12 Mar 2025 Date | | 0.3 Cons. EPS | 0.14 EPS |
| 17 Oct 2024 Date | | - Cons. EPS | 0.21 EPS |
| 16 Aug 2024 Date | | - Cons. EPS | 0.33 EPS |
| 17 Apr 2024 Date | | - Cons. EPS | - EPS |
| 0007 000739 1 month ago | Other | ¥0.36 Per Share |
| 0007 000739 23 May 2024 | Other | ¥0.32 Per Share |
| 0007 000739 22 May 2023 | Other | ¥0.3 Per Share |
| 0007 000739 18 Apr 2022 | Other | ¥0.28 Per Share |
| 0007 000739 29 Apr 2021 | Other | ¥0.24 Per Share |
| 9 Apr 2025 Date | | - Cons. EPS | - EPS |
| 12 Mar 2025 Date | | 0.3 Cons. EPS | 0.14 EPS |
| 17 Oct 2024 Date | | - Cons. EPS | 0.21 EPS |
| 16 Aug 2024 Date | | - Cons. EPS | 0.33 EPS |
| 17 Apr 2024 Date | | - Cons. EPS | - EPS |
Apeloa Pharmaceutical Co., Ltd. (000739) FAQ
What is the stock price today?
The current price is ¥14.44.
On which exchange is it traded?
Apeloa Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 000739.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.27%.
What is its market cap?
As of today, the market cap is 16.28B.
Has Apeloa Pharmaceutical Co., Ltd. ever had a stock split?
Apeloa Pharmaceutical Co., Ltd. had 1 splits and the recent split was on May 30, 2014.
Apeloa Pharmaceutical Co., Ltd. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Fangmeng Zhu CEO | XSHE Exchange | CNE000000Q45 ISIN |
| CN Country | 7,060 Employees | 22 May 2025 Last Dividend | 30 May 2014 Last Split | 9 May 1997 IPO Date |
Overview
Apeloa Pharmaceutical Co.,Ltd, founded in 1989 and headquartered in Dongyang, the People's Republic of China, is a prominent provider of raw materials and intermediates for the pharmaceutical industry. The company serves numerous pharmaceutical factories within China and extends its services internationally. Apeloa Pharmaceutical is recognized for its contribution to the pharmaceutical sector through its extensive offerings that cater to various therapeutic areas.
Products and Services
Preparation Products: Apeloa Pharmaceutical boasts a diverse portfolio of preparation products that target critical health areas. This range includes:
- Cardio-cerebrovascular: These products are designed to support the health of the heart and the brain, addressing conditions such as hypertension, heart failure, and stroke prevention.
- Anti-infection: Offering solutions to combat bacterial, viral, and fungal infections, these drugs are vital in managing and treating infectious diseases across a broad spectrum.
- Anti-tumor: Catering to the oncology segment, these products play a significant role in the fight against various types of cancer, providing patients with chemotherapy options and supportive care treatments.
- Anti-viral: In response to the global need for effective antiviral therapies, Apeloa's products in this category offer treatments for diseases like influenza, hepatitis, and other viral infections.
- Special Drugs: This category encompasses a range of treatments for less common conditions and diseases, reflecting Apeloa's commitment to addressing the healthcare needs of niche patient populations.
The company markets its products under several brands, including Tianliwei, Beshin, Yosemade, Jutai, and others, ensuring its presence in different therapeutic segments and leveraging brand recognition to foster trust and reliability among healthcare professionals and patients.
Contact Information
Address: No. 99 South Hengdian Road, Dongyang, China, 322118
Phone: 86 579 8655 7494
Website: https://www.apeloa.com
2025 © Marketlog. All Rights Reserved.
